Alana Harris Dent

Array ( [id] => 6038420 [patent_doc_number] => 20110091469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/976838 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21206 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091469.pdf [firstpage_image] =>[orig_patent_app_number] => 12976838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127667 [patent_doc_number] => 20110086800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/956503 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7019 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086800.pdf [firstpage_image] =>[orig_patent_app_number] => 12956503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039339 [patent_doc_number] => 20110092388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/953099 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47618 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092388.pdf [firstpage_image] =>[orig_patent_app_number] => 12953099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14700647 [patent_doc_number] => 10378058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer [patent_app_type] => utility [patent_app_number] => 12/943644 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 23531 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522667 [patent_doc_number] => 20120322075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Lung Tumor Markers and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/503410 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 16324 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9008946 [patent_doc_number] => 08524240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Diagnosis and therapy of hematological malignancies' [patent_app_type] => utility [patent_app_number] => 12/911227 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 8145 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12911227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560891 [patent_doc_number] => 20110274723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'CANCER IMMUNOTHERAPY AND METHOD OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/910778 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26493 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274723.pdf [firstpage_image] =>[orig_patent_app_number] => 12910778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335119 [patent_doc_number] => 20120201823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'APRIL ANTAGONISTS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/501702 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17532 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148740 [patent_doc_number] => 20110020335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Treatment of Cancers Expressing p95 ErbB2' [patent_app_type] => utility [patent_app_number] => 12/894236 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020335.pdf [firstpage_image] =>[orig_patent_app_number] => 12894236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008089 [patent_doc_number] => 20110060120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57' [patent_app_type] => utility [patent_app_number] => 12/882183 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9293 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060120.pdf [firstpage_image] =>[orig_patent_app_number] => 12882183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690156 [patent_doc_number] => 08389684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Tumor biomarker' [patent_app_type] => utility [patent_app_number] => 12/880265 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 10888 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12880265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790957 [patent_doc_number] => 20120052513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'GOLD SUB-NANOCLUSTERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/862480 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6761 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052513.pdf [firstpage_image] =>[orig_patent_app_number] => 12862480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738481 [patent_doc_number] => 08410252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'ULBP2 polypeptides' [patent_app_type] => utility [patent_app_number] => 12/862629 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 28351 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12862629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118599 [patent_doc_number] => 20110076272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'THERAPEUTIC METHODS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/860838 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31897 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076272.pdf [firstpage_image] =>[orig_patent_app_number] => 12860838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8674977 [patent_doc_number] => 08383089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Use of IMP3 as a prognostic marker for cancer' [patent_app_type] => utility [patent_app_number] => 12/858125 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30167 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12858125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8674977 [patent_doc_number] => 08383089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Use of IMP3 as a prognostic marker for cancer' [patent_app_type] => utility [patent_app_number] => 12/858125 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30167 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12858125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17695871 [patent_doc_number] => 11369572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Fas (Apo-1,CD95) targeted platforms for intracellular drug delivery [patent_app_type] => utility [patent_app_number] => 13/386349 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 18 [patent_no_of_words] => 11286 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300996 [patent_doc_number] => 20120183554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Biomarker' [patent_app_type] => utility [patent_app_number] => 13/383399 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9368 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10104927 [patent_doc_number] => 09140704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Serum markers associated with early and other stages of breast cancer' [patent_app_type] => utility [patent_app_number] => 13/384014 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 16591 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6264891 [patent_doc_number] => 20100297655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'SOCS-1 GENE METHYLATION IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/831176 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29241 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297655.pdf [firstpage_image] =>[orig_patent_app_number] => 12831176 [rel_patent_id] =>[rel_patent_doc_number] =>)